Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical CEO Shlomo Yanai delivers a press conference in Cologne, Germany, 18 March 2010. German generics producer Ratiopharm is sold to world's leading generic producer Teva Pharmaceutical at 3.625 billion euro.
Teva won't say whether R&D cuts include layoffs; Cipla inks deal for Iranian plant; | Fierce Pharma
News & Media
Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
AMC, Teva, launch coalition for equity through digital health
Teva, lured by $40M tax break, packs its bags for New Jersey HQ move | Fierce Pharma
Teva Pharmaceuticals - Wikipedia
Teva Reports Third Quarter 2021 Financial Results
The ALS Association, Huntington's Disease Society of America, and Teva Pharmaceuticals Launch Teva CNS Target Identification Challenge | The ALS Association
AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals | Business Wire
Teva Pharmaceuticals Launches Generic EpiPen for Children in US | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Av 5779 – August 21, 2019 | JewishPress.com
Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to
New branded drugs helping Teva Pharm move closer to growth | Reuters
Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire
Teva Pharmaceutical High Resolution Stock Photography and Images - Alamy
News & Media
Teva Reports First Quarter 2020 Financial Results | Business Wire
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
EU antitrust authorities launch probe of Teva over Copaxone drug | The Times of Israel
Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire
Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia | Business Wire
